UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The alteration of NK cells phenotypes related to the functions and dengue disease outcomes

Virus research, 2024-07, Vol.345, p.199382-199382, Article 199382

2024

Volltextzugriff (PDF)

B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape

Oncoimmunology, 2015-04, Vol.4 (4), p.e1001224-e1001224

2015

Volltextzugriff (PDF)

Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15

Frontiers in immunology, 2016-10, Vol.7, p.413-413

2016

Volltextzugriff (PDF)

Unraveling the non-fitness status of NK cells: Examining the NKp30 receptor and its isoforms distribution in HIV/HCV coinfected patients

Molecular immunology, 2024-08, Vol.172, p.9-16

2024

Volltextzugriff (PDF)

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

The Journal of experimental medicine, 2002-02, Vol.195 (3), p.343-351

2002

Volltextzugriff (PDF)

Dendritic cell derived cytokines in human natural killer cell differentiation and activation

Frontiers in immunology, 2013, Vol.4, p.365-365

2013

Volltextzugriff (PDF)

Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia

Oncology research and treatment, 2019-01, Vol.42 (4), p.197-203

2019

Volltextzugriff (PDF)

Deficiency of N-linked glycosylation impairs immune function of B7-H6

Frontiers in immunology, 2023-11, Vol.14, p.1255667-1255667

2023

Volltextzugriff (PDF)

RIG-I activation induces the release of extracellular vesicles with antitumor activity

Oncoimmunology, 2016-10, Vol.5 (10), p.e1219827-e1219827

2016

Volltextzugriff (PDF)

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer

Frontiers in oncology, 2022-03, Vol.12, p.814312-814312

2022

Volltextzugriff (PDF)

Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers

mAbs, 2024, Vol.16 (1), p.2315640-2315640

2024

Volltextzugriff (PDF)

NK cells in patients with chronic rhinosinusitis show decreased maturity and limited expression of functional receptors

Immunobiology (1979), 2020-03, Vol.225 (2), p.151890-151890, Article 151890

2020

Volltextzugriff (PDF)

Activatory Receptor NKp30 Predicts NK Cell Activation During Controlled Human Malaria Infection

Frontiers in immunology, 2019-12, Vol.10, p.2864-2864

2019

Volltextzugriff (PDF)

The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells

Oncoimmunology, 2016-07, Vol.5 (7), p.e1116674-e1116674

2016

Volltextzugriff (PDF)

Targeting NKG2D and NKp30 Ligands Shedding to Improve NK Cell-Based Immunotherapy

Critical reviews in immunology, 2016, Vol.36 (6), p.445-460

2016

Volltextzugriff (PDF)

Non‐fitness status of peripheral NK cells defined by decreased NKp30 and perforin, and increased soluble B7H6, in cervical cancer patients

Immunology, 2023-03, Vol.168 (3), p.538-553

2023

Volltextzugriff (PDF)

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

Oncoimmunology, 2017-01, Vol.6 (1), p.e1137418-e1137418

2017

Volltextzugriff (PDF)

On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality

Protein science, 2024-11, Vol.33 (11), p.e5176-n/a

2024

Volltextzugriff (PDF)

In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients

Frontiers in immunology, 2017-08, Vol.8, p.931-931

2017

Volltextzugriff (PDF)

Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study

British journal of anaesthesia : BJA, 2014-07, Vol.113, p.i56-i62

2014

Volltextzugriff (PDF)

PET Imaging of the Natural Killer Cell Activation Receptor NKp30

Journal of Nuclear Medicine, 2020-09, Vol.61 (9), p.1348-1354

2020

Volltextzugriff (PDF)

Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients

European journal of cancer (1990), 2019-02, Vol.108, p.88-96

2019

Volltextzugriff (PDF)

Broadening our knowledge of the differences between HIV-2 and HIV-1 innate sensing: HIV-2 infected cells selectively express B7-H6 and engage NKp30 on natural killer cells

AIDS (London), 2019-01, Vol.33 (1), p.153-154

2019

Volltextzugriff (PDF)

Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression

Frontiers in immunology, 2024-04, Vol.15, p.1388018-1388018

2024

Volltextzugriff (PDF)

Harnessing B7-H6 for Anticancer Immunotherapy: Expression, Pathways, and Therapeutic Strategies

International journal of molecular sciences, 2024-10, Vol.25 (19), p.10326

2024

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(112)

Sprache

Englisch
(112)

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Life Sciences & Biomedicine
(102)
Nkp30
(96)
Immunology
(74)
Humans
(68)
Killer Cells, Natural - Immunology
(45)
Natural Killer Cells
(33)
Female
(29)
Nk Cells
(28)
Cytotoxicity
(27)
Oncology
(25)
Adult
(22)
Nkp46
(22)
Animals
(20)
B7-H6
(20)
Ligands
(20)
Natural Cytotoxicity Triggering Receptor 3 - Metabolism
(19)
Killer Cells, Natural - Metabolism
(18)
Biochemistry & Molecular Biology
(17)
Cytotoxicity, Immunologic
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The alteration of NK cells phenotypes related to the functions and dengue disease outcomes

B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape

Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15

Unraveling the non-fitness status of NK cells: Examining the NKp30 receptor and its isoforms distribution in HIV/HCV coinfected patients

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

Dendritic cell derived cytokines in human natural killer cell differentiation and activation

Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia

Deficiency of N-linked glycosylation impairs immune function of B7-H6

RIG-I activation induces the release of extracellular vesicles with antitumor activity

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer

Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers

NK cells in patients with chronic rhinosinusitis show decreased maturity and limited expression of functional receptors

Activatory Receptor NKp30 Predicts NK Cell Activation During Controlled Human Malaria Infection

The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells

Targeting NKG2D and NKp30 Ligands Shedding to Improve NK Cell-Based Immunotherapy

Non‐fitness status of peripheral NK cells defined by decreased NKp30 and perforin, and increased soluble B7H6, in cervical cancer patients

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality

In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients

Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study

PET Imaging of the Natural Killer Cell Activation Receptor NKp30

Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients

Broadening our knowledge of the differences between HIV-2 and HIV-1 innate sensing: HIV-2 infected cells selectively express B7-H6 and engage NKp30 on natural killer cells

Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression

Harnessing B7-H6 for Anticancer Immunotherapy: Expression, Pathways, and Therapeutic Strategies

Suchergebnisse filtern